Z36.82
Encounter for antenatal screening for nuchal translucency
Clinical Classification Guidelines
Medical Intelligence & Overview
An encounter for antenatal screening for nuchal translucency involves a specialized ultrasound test performed during pregnancy to assess the risk of chromosomal abnormalities in the developing fetus. This screening focuses on measuring the fluid at the back of the baby's neck, known as nuchal translucency, which can provide early clues about potential genetic conditions. The test is typically offered to pregnant women between 11 and 14 weeks of gestation and is an essential part of prenatal care for detecting possible issues early in pregnancy.
Causes & Symptoms
Clinical Causes: Routine prenatal care to assess fetal health Family history of genetic or chromosomal disorders Advanced maternal age (over 35 years old) History of previous pregnancies with genetic abnormalities Other prenatal screening protocols recommended by healthcare providers
Key Symptoms: No symptoms are typically associated with the screening itself, as it is a diagnostic procedure rather than a symptomatic condition Anxiety or concern about fetal health or potential genetic risks In some cases, physical signs indicating genetic conditions may be observed later in pregnancy, but these are not part of the screening process
Diagnostic & Treatment
Diagnosis Path: The diagnosis in this context refers to the assessment of risk based on ultrasound measurements and, if necessary, further diagnostic tests. During the screening, a specialized ultrasound technician measures the nuchal translucency, and the data is combined with maternal blood tests to estimate the likelihood of chromosomal abnormalities such as Down syndrome, Edwards syndrome, or Patau syndrome. A high-risk result may lead to more invasive diagnostic procedures like chorionic villus sampling (CVS) or amniocentesis to confirm any abnormalities.
Treatment Protocols: As this is a screening test, the main purpose is early detection and counseling rather than treatment. Based on the screening results, healthcare providers may recommend additional diagnostic tests, genetic counseling, or preparations for managing identified conditions. If an abnormality is confirmed, options and management plans can be discussed, including potential interventions, further testing, or planning for specialized neonatal care after birth.
Clinical Advice & FAQs
Billing Guidance
Is Z36.82 a billable ICD-10 code?
Yes, Z36.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z36.82?
Clinical documentation must specify the nature of Encounter for antenatal screening for nuchal translucency and any associated comorbidities for accurate reporting.
Cite this Clinical Reference